Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Table of Contents

September-October 2024; Volume 21,Issue 5

Review

  • Open Access
    Pharmacogenetics of Toxicities Related to Endocrine Treatment in Breast Cancer: A Systematic Review and Meta-analysis
    KINAN MOKBEL, MICHAEL WEEDON, VICTORIA MOYE and LEIGH JACKSON
    Cancer Genomics & Proteomics September 2024, 21 (5) 421-438; DOI: https://doi.org/10.21873/cgp.20461

Articles

  • Open Access
    Worse Wilms’ Tumor Outcomes Associated With Chemical Complementarity for Multiple T-Cell Receptor CDR3-CMV Epitope Pairs
    KASEY L. RIGBY, MICHAEL J. DIAZ, ETIENNE C. GOZLAN, DOROTTYA B. KACSOH, JOANNA J. SONG, TABITHA R. HUDOCK, ANDREA CHOBRUTSKIY, BORIS I. CHOBRUTSKIY and GEORGE BLANCK
    Cancer Genomics & Proteomics September 2024, 21 (5) 439-447; DOI: https://doi.org/10.21873/cgp.20462
  • Open Access
    The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory
    NIKOLAOS TSOULOS, KONSTANTINOS AGIANNITOPOULOS, KEVISA POTSKA, ANASTASIA KATSELI, CHRISTINA NTOGKA, GEORGIA PEPE, DIMITRA BOUZARELOU, ATHANASIOS PAPATHANASIOU, DIMITRIOS GRIGORIADIS, GEORGIOS N. TSAOUSIS, HELEN GOGAS, THEODORE TROUPIS, KONSTANTINOS PAPAZISIS, IOANNIS NATSIOPOULOS, VASSILEIOS VENIZELOS, KYRIAKOS AMARANTIDIS, STYLIANOS GIASSAS, CHRISTOS PAPADIMITRIOU, ELENA FOUNTZILAS, MAROULIO STATHOULOPOULOU, ANNA KOUMARIANOU, GRIGORIOS XEPAPADAKIS, ALEXANDRU BLIDARU, DANIELA ZOB, OANA VOINEA, MUSTAFA ÖZDOĞAN, MAHMUT ÇERKEZ ERGÖREN, ALINTA HEGMANE, EIRINI PAPADOPOULOU, GEORGE NASIOULAS and CHRISTOS MARKOPOULOS
    Cancer Genomics & Proteomics September 2024, 21 (5) 448-463; DOI: https://doi.org/10.21873/cgp.20463
  • Open Access
    Terrein Exhibits Anti-tumor Activity by Suppressing Angiogenin Expression in Malignant Melanoma Cells
    TAIRA HIROSE, YUKI KUNISADA, KOICHI KADOYA, HIROKI MANDAI, YUMI SAKAMOTO, KYOICHI OBATA, KISHO ONO, HIROAKI TAKAKURA, KAZUHIRO OMORI, SHOGO TAKASHIBA, SEIJI SUGA and SOICHIRO IBARAGI
    Cancer Genomics & Proteomics September 2024, 21 (5) 464-473; DOI: https://doi.org/10.21873/cgp.20464
  • Open Access
    Desert Hedgehog Down-regulation Mediates Inhibition of Proliferation by γ-Glutamylcyclotransferase Knockdown in Murine Glioblastoma Stem Cells
    MASAYA MORI, HIROMI II, MITSUGU FUJITA, KOZUE NOSE, AYAKO SHIMADA, RISA SHIRAKI, YUHI SONE, CHIAMI MOYAMA, KEIKO TANIGUCHI and SUSUMU NAKATA
    Cancer Genomics & Proteomics September 2024, 21 (5) 474-484; DOI: https://doi.org/10.21873/cgp.20465
  • Open Access
    DNA Methylation in Recurrent Glioblastomas: Increased TEM8 Expression Activates the Src/PI3K/AKT/GSK-3β/B-Catenin Pathway
    PARAMITA KUNDU, RUCHI JAIN, NANDAKI NAG KANURI, ARIVAZHAGAN ARIMAPPAMAGAN, VANI SANTOSH and PATURU KONDAIAH
    Cancer Genomics & Proteomics September 2024, 21 (5) 485-501; DOI: https://doi.org/10.21873/cgp.20466
  • Open Access
    Impacts of Matrix Metalloproteinase-2 Promoter Genotypes on Breast Cancer Risk
    CHIH-CHIANG HUNG, CHUNG-LIN TSAI, YU-TING CHIN, YUN-CHI WANG, CHIA-HUA LIU, MENG-LIANG LIN, SHIH-SHUN CHEN, JIE-LONG HE, CHIA-WEN TSAI, CHEN-HSIEN SU, DA-TIAN BAU and WEN-SHIN CHANG
    Cancer Genomics & Proteomics September 2024, 21 (5) 502-510; DOI: https://doi.org/10.21873/cgp.20467
  • Open Access
    P53 Status Influences the Anti-proliferative Effect Induced by IFITM1 Inhibition in Estrogen Receptor-positive Breast Cancer Cells
    DER SHENG SUN, JUNG-SOOK YOON, YONG-SEOK KIM and HYE SUNG WON
    Cancer Genomics & Proteomics September 2024, 21 (5) 511-522; DOI: https://doi.org/10.21873/cgp.20468
  • Open Access
    Targeting Bmi1 for Enhancing Anoikis Sensitivity and Inhibiting Metastasis in Colorectal Cancer
    YIN-CHOU HSU, CHI-WEN LUO, SHU-JYUAN CHANG, CHIAO-YING LAI, YU-TZU YANG, YI-ZI CHEN, WANG-TA LIU, CHUN-CHIEH WU, CHEUK-KWAN SUN, MING-FENG HOU and MEI-REN PAN
    Cancer Genomics & Proteomics September 2024, 21 (5) 523-532; DOI: https://doi.org/10.21873/cgp.20469
  • Open Access
    PIK3CA Mutated Colorectal Cancers Without KRAS, NRAS and BRAF Mutations Possess Common and Potentially Targetable Mutations in Epigenetic Modifiers and DNA Damage Response Genes
    IOANNIS A. VOUTSADAKIS
    Cancer Genomics & Proteomics September 2024, 21 (5) 533-548; DOI: https://doi.org/10.21873/cgp.20470
Back to top
PreviousNext

In this issue

Cancer Genomics - Proteomics: 21 (5)
Cancer Genomics & Proteomics
Vol. 21, Issue 5
September-October 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Worse Wilms’ Tumor Outcomes Associated With Chemical Complementarity for Multiple T-Cell Receptor CDR3-CMV Epitope Pairs
  • PIK3CA Mutated Colorectal Cancers Without KRAS, NRAS and BRAF Mutations Possess Common and Potentially Targetable Mutations in Epigenetic Modifiers and DNA Damage Response Genes
  • The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory
  • Pharmacogenetics of Toxicities Related to Endocrine Treatment in Breast Cancer: A Systematic Review and Meta-analysis
  • Terrein Exhibits Anti-tumor Activity by Suppressing Angiogenin Expression in Malignant Melanoma Cells
Sign up for alerts

Jump to

  • Review
  • Articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Cancer & Genome Proteomics

© 2025 Cancer Genomics & Proteomics

Powered by HighWire